NO984739L - Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer - Google Patents
Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorerInfo
- Publication number
- NO984739L NO984739L NO984739A NO984739A NO984739L NO 984739 L NO984739 L NO 984739L NO 984739 A NO984739 A NO 984739A NO 984739 A NO984739 A NO 984739A NO 984739 L NO984739 L NO 984739L
- Authority
- NO
- Norway
- Prior art keywords
- cyclopent
- piperidines
- indole
- spiro
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63064196A | 1996-04-10 | 1996-04-10 | |
| PCT/US1997/003864 WO1997037992A2 (en) | 1996-04-10 | 1997-03-10 | Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO984739D0 NO984739D0 (no) | 1998-10-09 |
| NO984739L true NO984739L (no) | 1998-12-09 |
Family
ID=24527997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO984739A NO984739L (no) | 1996-04-10 | 1998-10-09 | Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0892802B1 (pt) |
| JP (1) | JP3615225B2 (pt) |
| KR (1) | KR100270145B1 (pt) |
| CN (1) | CN1233249A (pt) |
| AR (1) | AR006553A1 (pt) |
| AT (1) | ATE252581T1 (pt) |
| AU (1) | AU708124B2 (pt) |
| BR (1) | BR9708563A (pt) |
| CA (1) | CA2251545C (pt) |
| DE (1) | DE69725713T2 (pt) |
| DK (1) | DK0892802T3 (pt) |
| ES (1) | ES2207718T3 (pt) |
| HU (1) | HUP9902755A3 (pt) |
| IL (1) | IL126003A0 (pt) |
| NO (1) | NO984739L (pt) |
| PT (1) | PT892802E (pt) |
| WO (1) | WO1997037992A2 (pt) |
| ZA (1) | ZA972984B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1572299A (zh) | 1998-09-30 | 2005-02-02 | 武田药品工业株式会社 | 改善膀胱排泄能力的药物 |
| CA2788656A1 (en) | 2010-02-16 | 2011-08-25 | Pfizer Inc. | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
| AU2016353446B2 (en) | 2015-11-12 | 2022-05-19 | Afasci, Inc. | Ion channel inhibitory compounds, pharmaceutical formulations and uses |
| AR116020A1 (es) | 2018-09-03 | 2021-03-25 | Bayer Ag | COMPUESTOS DE 3,9-DIAZAESPIRO[5.5]UNDECANO COMO INHIBIDORES DE GGTasa I Y SU USO PARA EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS |
| WO2020048827A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds |
| WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
-
1997
- 1997-03-01 IL IL12600397A patent/IL126003A0/xx unknown
- 1997-03-10 JP JP53619797A patent/JP3615225B2/ja not_active Expired - Fee Related
- 1997-03-10 AT AT97908068T patent/ATE252581T1/de not_active IP Right Cessation
- 1997-03-10 CN CN97193690A patent/CN1233249A/zh active Pending
- 1997-03-10 BR BR9708563A patent/BR9708563A/pt not_active IP Right Cessation
- 1997-03-10 KR KR1019980708047A patent/KR100270145B1/ko not_active IP Right Cessation
- 1997-03-10 AU AU19909/97A patent/AU708124B2/en not_active Ceased
- 1997-03-10 CA CA002251545A patent/CA2251545C/en not_active Expired - Fee Related
- 1997-03-10 WO PCT/US1997/003864 patent/WO1997037992A2/en active IP Right Grant
- 1997-03-10 HU HU9902755A patent/HUP9902755A3/hu unknown
- 1997-03-10 PT PT97908068T patent/PT892802E/pt unknown
- 1997-03-10 EP EP97908068A patent/EP0892802B1/en not_active Expired - Lifetime
- 1997-03-10 DE DE69725713T patent/DE69725713T2/de not_active Expired - Fee Related
- 1997-03-10 DK DK97908068T patent/DK0892802T3/da active
- 1997-03-10 ES ES97908068T patent/ES2207718T3/es not_active Expired - Lifetime
- 1997-04-08 AR ARP970101376A patent/AR006553A1/es not_active Application Discontinuation
- 1997-04-08 ZA ZA9702984A patent/ZA972984B/xx unknown
-
1998
- 1998-10-09 NO NO984739A patent/NO984739L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0892802B1 (en) | 2003-10-22 |
| CA2251545C (en) | 2002-01-08 |
| PT892802E (pt) | 2004-03-31 |
| DK0892802T3 (da) | 2003-12-01 |
| DE69725713D1 (de) | 2003-11-27 |
| AU1990997A (en) | 1997-10-29 |
| NO984739D0 (no) | 1998-10-09 |
| ATE252581T1 (de) | 2003-11-15 |
| HUP9902755A3 (en) | 2000-05-29 |
| IL126003A0 (en) | 1999-04-11 |
| WO1997037992A2 (en) | 1997-10-16 |
| KR20000005328A (ko) | 2000-01-25 |
| ZA972984B (en) | 1997-11-03 |
| JP3615225B2 (ja) | 2005-02-02 |
| EP0892802A1 (en) | 1999-01-27 |
| CN1233249A (zh) | 1999-10-27 |
| JP2002509520A (ja) | 2002-03-26 |
| BR9708563A (pt) | 1999-08-03 |
| AR006553A1 (es) | 1999-09-08 |
| HUP9902755A2 (hu) | 2000-03-28 |
| CA2251545A1 (en) | 1997-10-16 |
| AU708124B2 (en) | 1999-07-29 |
| DE69725713T2 (de) | 2004-05-13 |
| KR100270145B1 (ko) | 2000-11-01 |
| ES2207718T3 (es) | 2004-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091761L (no) | Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav | |
| NO991732L (no) | Nye heterocyklylmetylsubstituerte pyrazolderivater | |
| MY131298A (en) | 5-heteroyl indole derivatives | |
| BG101806A (en) | Indole derivatives as 5-ht receptor antagoniss | |
| NO20005454L (no) | Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmåte for fremstilling derav | |
| PL331091A1 (en) | Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor | |
| NO986111D0 (no) | Anvendelse av K-252A derivat for behandling av perifere og sentrale nervefo | |
| NO963731L (no) | Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister | |
| NO20021541L (no) | 5-beta-sapogenin- og pseudosapogeninderivater samt deres anvendelse ved behandling av demens | |
| NO20002787L (no) | Nye forbindelser | |
| NO985574L (no) | FremgangsmÕter og preparater anvendelige for inhibering av angiogenese | |
| FI956074A (fi) | Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia | |
| NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
| NO963850L (no) | Heterosykliske forbindelser, deres fremstilling og anvendelse | |
| NO984739L (no) | Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer | |
| NO985671D0 (no) | Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte for deres fremstilling og farmas°ytiske preparater som inneholder dem | |
| DK0556332T3 (da) | Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet | |
| TR199700956T1 (xx) | Indazolkarboksamidler. | |
| DE69828999D1 (de) | 1-(4-(1-(4-fluorphenyl)-1h-indol-3-yl)1-butyl)-spiro-(isobenzofuran-1(3h),4'-piperidin)-hydrohalogenide | |
| ATE315933T1 (de) | Therapeutische behandlung von kardiovaskularen krankheiten | |
| NO984624D0 (no) | Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav | |
| DK0888114T3 (da) | Anvendelse af (+)-alfa-(2,3-dimethoxyphenyl)-1-[2-(4-flourphenyl)-ethyl]-4-piperidinmethanol til behandling af depressive lidelser og bipolare lidelser | |
| PL318812A1 (en) | Method of identifying compounds suitable for treating auto-aggressive diseases | |
| NO991589D0 (no) | Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler | |
| NO975682L (no) | Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler |